P. Bontemps

1.4k citations

34 papers · 1.1k indexed · h-index 10

Impact in

Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
Radiation top 5%
- Advanced Radiotherapy Techniques

Papers in

Otorhinolaryngology 11
- Head and Neck Cancer Studies 11
Cancer Research 10
- Breast Cancer Treatment Studies 9

Co-authors: S Schraub R. Le Fur Jean-Claude Horiot Antoine Lusinchi M. Bolla Laurence Collette M. Mercier M. Piérart
Journals: Radiotherapy and Oncology (4 papers)European Journal of Cancer (4 papers)Cancer Research (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)The Breast (2 papers)
Partner nations: France Switzerland Belgium

In The Last Decade

P. Bontemps

30 papers receiving 1.0k citations

Peers

Countries citing papers authored by P. Bontemps

Since Specialization

Citations

This map shows the geographic impact of P. Bontemps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Bontemps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Bontemps more than expected).

Fields of papers citing papers by P. Bontemps

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Bontemps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Bontemps. The network helps show where P. Bontemps may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P. Bontemps, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Bontemps Line = papers co-authored together P. Bontemps links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases Cancer/Radiothérapie ·钟祖华, Roger Sun, Hardwiki Diwantara, Devita Hangielia, Jorge Rouvier, Olivier Mauvais, S. Bockel, Aurélien Louvrier, H. G. Langford, P. Bontemps, Cécile Ortholan, Jean Bourhis, Анисимова Надежда Викторовна, Ivan Enzo Gargano	2020	7
2	Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation PLoS ONE ·S.F. Jafarova, Marie‐Laure Tanguy, Paul Cottu, Brigitte De La Lande, P. Bontemps, C. Lemanski, Pierre Baumann, Alexia Savignoni, Christelle Lévy, Karine Peignaux, A. Reynaud-Bougnoux, Yashinta Marlina Faot, Youlia Kirova	2019	6
3	A sore throat Journal of Stomatology Oral and Maxillofacial Surgery ·Abdullah Azhar, Mikheev Vv, P. Bontemps, Roman Hossein Khonsari	2019	2
4	Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study Cancer/Radiothérapie ·Ari Untoro Candra, Lisa Belin, Paul Cottu, P. Bontemps, C. Lemanski, 隆坂下, Pierre Baumann, J.S. Scolapio, Christelle Lévy, Karine Peignaux, A. Reynaud-Bougnoux, Fabrice Denis, Yashinta Marlina Faot, Ekua A. Beneman, Youlia Kirova	2018	2
5	Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer British Journal of Radiology ·Ekua A. Beneman, Lisa Belin, P. Cottu, P. Bontemps, C. Lemanski, 隆坂下, Pierre Baumann, J.S. Scolapio, Christelle Lévy, Karine Peignaux, A. Reynaud-Bougnoux, Fabrice Denis, Yashinta Marlina Faot, Marc A. Bollet, Jana Henrike Leist, R. Dendale, Frank Campana, Alain Fourquet, Youlia Kirova	2015	9
6	Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer The Breast ·Ekua A. Beneman, Lisa Belin, Paul Cottu, P. Bontemps, C. Lemanski, Brigitte De La Lande, Pierre Baumann, J.S. Scolapio, Christelle Lévy, Karine Peignaux, Philippe Bougnoux, Fabrice Denis, Marc A. Bollet, R. Dendale, Jana Henrike Leist, François Campana, Alain Fourquet, Youlia Kirova	2014	6
7	Fibrome desmoplastique de l’os zygomatique Revue de Stomatologie de Chirurgie Maxillo-faciale et de Chirurgie Orale ·P. Bontemps, Maiken K. Brix, É. Simon	2014	3
8	Discordance in early breast cancer for tumour grade, Estrogen Receptor, Progesteron Receptors and Human Epidermal Receptor-2 status between core needle biopsy and surgical excisional primary tumour The Breast ·Véronique Lorgis, Muhamad Shafiq Mohd Ali, Cristian Villanueva, L. Chaigneau, Antoine Thiery-Vuillemin, Thierry Nguyen, Martin Demarchi, Fernando Bazán, Kathryn Gaetke, 权太范, 義春植木, P. Bontemps, Xavier Pivot	2011	59
9	Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent Radiotherapy and Oncology ·J. Tortochaux, Yungan Tao, Elodie Tournay, M. Lapeyre, F. Lesaunier, É. Bardet, François Janot, Antoine Lusinchi, E Benhamou, P. Bontemps, P. Maingon, G. Calais, Nicolas Daly‐Schveitzer, Pierre Verrelle, Jean Bourhis	2011	65
10	Phase III randomized French multicentric study to evaluate the impact of a localized 16-Gy boost after conservative surgery and a 50-Gy whole-breast irradiation in breast ductal carcinoma in situ (the BONBIS trial). Journal of Clinical Oncology ·D. Azria, D. Cowen, C. Bourgier, 隆坂下, S. Gourgou-Bourgade, Malikova Ay, Lebohang Radebe, I. Latorzeff, Olivier Pradier, P. Maingon, I. Lecouillard, P. Bontemps, Stephen B. Ellis, Christelle Lévy, C.W.G.J. Leeuwen, S. Racadot, L.O. Scaldarella, Wei Xin-yu, Alberto Ceccherelli, C. Lemanski	2011	6
11	Seconds cancers après radiothérapie pour séminome testiculaire : à propos de deux cas Cancer/Radiothérapie ·S. Servagi-Vernat, G. Créhange, F. Lorchel, P. Bontemps, J.F. Bosset	2006	2
12	Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy Acta Paediatrica ·S. Cadranel, P. Bontemps, Stéphanie Van Biervliet, Philippe Alliët, Ghelfi Barbara, Guy Vandenhoven, Yvan Vandenplas	2006	13
13	Docetaxel Plus 5-Fluorouracil in Locally Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck American Journal of Clinical Oncology ·Dominique Genet, Didier Cupissol, G. Calais, P. Bontemps, Hugues Bourgeois, Radwa Fathy Fawaz Kassem, Tanti Widia Nurdiani, Belguendouz Bendahmane, H. Tsuchiya, N. Tubiana-Mathieu	2004	19
14	Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study European Journal of Cancer ·Mahmut Özsahin, A. Zouhair, S. Villà, Guy Storme, B. Chauvet, Daniel Taussky, Vo Ha Khanh, Gerhard Ries, P. Bontemps, Philippe Coucke, R.O. Mirimanoff	1999	122
15	Accelerated fractionation compared ta conventional fractionation improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of EORTC 22851 randomized trial Cancer/Radiothérapie ·松浦將行, P. Bontemps, Irene Riaño De Hoz, R. Le Fur, 克也長山, M. Bolla, J. Bernier, A. Lusinchi, Martin Stuschke, J. López-Torrecilla, Ulf Örnemark, M. Piérart, R. DeSouza	1998	2
16	Les complications rectales de la radiothérapie Cancer/Radiothérapie ·保壽黒沢, P. Bontemps, А А Михайленко	1997	4
17	Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial Radiotherapy and Oncology ·Jean-Claude Horiot, P. Bontemps, Walter Van den Bogaert, R. Le Fur, Лолита Мищенко, M. Bolla, Jacques Bernier, Antoine Lusinchi, Martin Stuschke, J. López-Torrecilla, Adrian C. Begg, M. Piérart, Laurence Collette	1997	389
18	Radiothérapie hyperfractionnée et accélérée dans les cancers de la tête et du cou: résultats des essais de l'EORTC et impact sur la pratique clinique Bernardine Godong, P. Bontemps, Ulf Örnemark, R. Le Fur, W. Van den Bogaert, M. Bolla, Thomas Nguyen, Лолита Мищенко, J. Bernier, A. Lusinchi, Frans Asaribab, Dylan M.T. Guss, Shikha Shah, Laurence Collette, M. van Glabbeke, M. Piérart	1996	9
19	role of alcohol and tobacco in the aetiology of head and neck cancer: A case-control study in the doubs region of France European Journal of Cancer Part B Oral Oncology ·雅之表, S Schraub, M. Mercier, P. Bontemps	1995	126
20	The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim report International Journal of Radiation OncologyBiologyPhysics ·A.C. Begg, Ingrid Hofland, L. Moonen, Harry Bartelink, S Schraub, P. Bontemps, R. Le Fur, W. Van den Bogaert, Robert J.L. Caspers, M. van Glabbeke, Jean-Claude Horiot	1990	158

About P. Bontemps

P. Bontemps is a scholar working on Otorhinolaryngology, Cancer Research, Radiation, Oncology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (11 papers), Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (9 papers), Advanced Radiotherapy Techniques (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Head and Neck Surgical Oncology (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Otorhinolaryngology (505 citations), Radiation (176 citations), Pulmonary and Respiratory Medicine (400 citations), Cancer Research (171 citations) and Oncology (297 citations). P. Bontemps has collaborated with scholars based in France, Switzerland and Belgium. Frequent co-authors include S Schraub, R. Le Fur, Jean-Claude Horiot, Antoine Lusinchi, M. Bolla, Laurence Collette, M. Mercier, M. Piérart, Martin Stuschke and Jacques Bernier. Their work appears in journals such as Radiotherapy and Oncology, European Journal of Cancer, Cancer Research, International Journal of Radiation Oncology*Biology*Physics and The Breast.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact